Abstract: Disclosed are methods and devices for securing a solar panel racking system to a tile roof, without removing roof tiles. The devices and method in combination may operate under severe weather conditions such as hurricanes, typhoons, and other tropical cyclones. An installer positions a stanchion through a hole in one of the roof tiles in the tile roof and onto a layer of polyurethane foam positioned over a layer of waterproof roof adhesive sealant. The installer extends the threaded fasteners obliquely through the stanchion, the layer of polyurethane foam, and the layer of waterproof roof adhesive sealant into the roof deck. The waterproof adhesive sealant bonds to the roof underlayment and creates a waterproof seal between the threaded fasteners and the roof deck.

Abstract: A modular storage structure can be constructed from a number of modular wall panels and modular roof panels. Multiple modular wall panels can be joined to form a wall system of the storage structure. The wall panels can be serially connected together such that a J-shaped interlock member of one panel is in abutting relationship with a corresponding J-shaped interlock member of another wall panel to define a series of wall stud assemblies adapted to receive fasteners for joining wall layers. The roof panels can be serially connected together in a similar fashion. In embodiments, the storage structure can be constructed such that it meets the predetermined requirements for a fire rating (e.g. a 2-hour or a 4-hour fire rating).

Abstract: A modular storage structure can be constructed from a number of modular wall panels and modular roof panels. Multiple modular wall panels can be joined to form a wall system of the storage structure. The wall panels can be serially connected together such that a J-shaped interlock member of one panel is in abutting relationship with a corresponding J-shaped interlock member of another wall panel to define a series of wall stud assemblies adapted to receive fasteners for joining wall layers. The roof panels can be serially connected together in a similar fashion. In embodiments, the storage structure can be constructed such that it meets the predetermined requirements for a fire rating (e.g. a 2-hour or a 4-hour fire rating).

Abstract: Purified genes encoding cytokine from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding this molecule are provided. Methods of using said reagents and diagnostic kits are also provided.

Abstract: Purified genes encoding cytokine from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding this molecule are provided. Methods of using said reagents and diagnostic kits are also provided.

Abstract: Purified genes encoding cytokine from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding this molecule are provided. Methods of using said reagents and diagnostic kits are also provided.

Abstract: Purified genes encoding cytokine from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding this molecule are provided. Methods of using said reagents and diagnostic kits are also provided.

Abstract: Purified genes encoding cytokine from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding this molecule are provided. Methods of using said reagents and diagnostic kits are also provided.

Abstract: Purified genes encoding cytokine from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding this molecule are provided. Methods of using said reagents and diagnostic kits are also provided.

Abstract: Compositions and methods for using mammalian CCR8 receptor proteins, antagonists and related reagents to treat diseases or conditions associated with Th2-mediated responses in an individual, especially asthma, are provided. The methods comprise administering a therapeutically effective amount of a CCR8 antagonist, alone or in combination with other therapeutic reagents. Also provided are methods for screening for therapeutics. Genetically-engineered animals and their use as models of molecular mechanism are also provided.

Abstract: Purified genes encoding cytokine from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding this molecule are provided. Methods of using said reagents and diagnostic kits are also provided.

Abstract: The present invention relates to a non-human transgenic mouse containing a constitutively active G-protein coupled receptor, which produces Kaposi's sarcoma-like symptoms. The transgenic mouse is useful in identification of reagents for the prevention, treatment and/or cure of diseases related to production of proliferative vascular lesions, including Kaposi's sarcoma.

Abstract: Compositions and methods for using mammalian CCR8 receptor proteins, antagonists and related reagents to treat diseases or conditions associated with Th2-mediated responses in an individual, especially asthma, are provided. The methods comprise administering a therapeutically effective amount of a CCR8 antagonist, alone or in combination with other therapeutic reagents. Also provided are methods for screening for therapeutics. Genetically-engineered animals and their use as models of molecular mechanism are also provided.

Abstract: Compositions and methods for using mammalian CCR6 and MIP-3&agr; proteins to treat an abnormal physiological condition in an individual. The methods comprise administering a therapeutically effective amount of CCR6 or MIP-3&agr; alone, or in combination with other therapeutic reagents; or a CCR6 or MIP-3&agr; antagonist. Genetically-engineered animals and their use as models of molecular mechanism are also provided.